BBA
Baker Bros. Advisors’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.2M | Hold |
3,731,695
| – | – | 0.51% | 24 |
|
|
2025
Q1 | $50.7M | Hold |
3,731,695
| – | – | 0.56% | 20 |
|
|
2024
Q4 | $76.1M | Hold |
3,731,695
| – | – | 0.81% | 18 |
|
|
2024
Q3 | $109M | Hold |
3,731,695
| – | – | 1.13% | 14 |
|
|
2024
Q2 | $86.6M | Hold |
3,731,695
| – | – | 1.11% | 15 |
|
|
2024
Q1 | $76.6M | Buy |
3,731,695
+1,124,499
| +43% | +$23.1M | 0.96% | 15 |
|
|
2023
Q4 | $56M | Buy |
2,607,196
+315,193
| +14% | +$6.76M | 0.64% | 20 |
|
|
2023
Q3 | $47.3M | Buy |
2,292,003
+836,681
| +57% | +$17.3M | 0.27% | 24 |
|
|
2023
Q2 | $42.9M | Buy |
1,455,322
+366,584
| +34% | +$10.8M | 0.25% | 27 |
|
|
2023
Q1 | $25.1M | Hold |
1,088,738
| – | – | 0.14% | 34 |
|
|
2022
Q4 | $30.3M | Buy |
1,088,738
+500,000
| +85% | +$13.9M | 0.18% | 30 |
|
|
2022
Q3 | $18.1M | Hold |
588,738
| – | – | 0.12% | 52 |
|
|
2022
Q2 | $17.3M | Buy |
588,738
+500,000
| +563% | +$14.7M | 0.1% | 52 |
|
|
2022
Q1 | $2.86M | Hold |
88,738
| – | – | 0.02% | 98 |
|
|
2021
Q4 | $3.96M | Hold |
88,738
| – | – | 0.02% | 97 |
|
|
2021
Q3 | $4.48M | Hold |
88,738
| – | – | 0.02% | 99 |
|
|
2021
Q2 | $6.96M | Hold |
88,738
| – | – | 0.03% | 88 |
|
|
2021
Q1 | $5.07M | Hold |
88,738
| – | – | 0.02% | 94 |
|
|
2020
Q4 | $7.43M | Sell |
88,738
-10,662
| -11% | -$893K | 0.03% | 83 |
|
|
2020
Q3 | $3.56M | Sell |
99,400
-5,500
| -5% | -$197K | 0.01% | 87 |
|
|
2020
Q2 | $2.54M | Hold |
104,900
| – | – | 0.01% | 96 |
|
|
2020
Q1 | $1.84M | Buy |
+104,900
| New | +$1.84M | 0.01% | 92 |
|